PHARMAC looking to fund medicines for lung and ovarian cancer


16 December 2021 - PHARMAC is considering funding a bundle deal which would give New Zealanders more effective treatment options for lung cancer and ovarian cancer. 

The bundle deal also includes a new medicine for people with severe eosinophilic asthma.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , New Zealand , Funding